Intradermal Vaccination for Monkeypox - Benefits for Individual and Public Health

N Engl J Med. 2022 Sep 29;387(13):1151-1153. doi: 10.1056/NEJMp2211311. Epub 2022 Aug 31.

Authors

John T Brooks¹, Peter Marks¹, Robert H Goldstein¹, Rochelle P Walensky¹

Affiliation

¹ From the Multinational Monkeypox Outbreak Response (J.T.B.) and the Office of the Director (R.H.G., R.P.W.), Centers for Disease Control and Prevention, Atlanta; and the Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (P.M.).

PMID: 36044621
DOI: 10.1056/NEJMp2211311

No abstract available

MeSH terms

Humans
Injections, Intradermal
Monkeypox virus
Mpox (monkeypox)* / epidemiology
Mpox (monkeypox)* / prevention & control
Public Health*
Smallpox
Smallpox Vaccine* / administration & dosage
Smallpox Vaccine* / therapeutic use
Vaccination

Substances

Smallpox Vaccine